BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 27677266)

  • 1. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
    Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
    Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
    Sutherland S; Meiser B; Kaur R; Mitchell G; Kirk J; Peate M; Tim Wong WK; Goodwin A
    Breast J; 2019 Jan; 25(1):34-40. PubMed ID: 30525267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey.
    Smith SG; Foy R; McGowan J; Kobayashi LC; Burn J; Brown K; Side L; Cuzick J
    Fam Cancer; 2017 Oct; 16(4):509-516. PubMed ID: 28434157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicians' opinions on recommending aspirin to prevent colorectal cancer to Australians aged 50-70 years: a qualitative study.
    Milton S; McIntosh J; Yogaparan T; Alphonse P; Saya S; Karnchanachari N; Nguyen P; Lau P; Macrae F; Emery J
    BMJ Open; 2021 Feb; 11(2):e042261. PubMed ID: 33550247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
    Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
    Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
    N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
    Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis.
    Petersen J; Koptiuch C; Wu YP; Mooney R; Elrick A; Szczotka K; Keener M; Pappas L; Kanth P; Soisson A; Kohlmann W; Kaphingst KA
    Patient Educ Couns; 2018 Nov; 101(11):2011-2017. PubMed ID: 30097381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For Women, Lynch Syndrome Is About More than Colon Cancer.
    Parker WM; Hennig K; Burton-Chase AM
    Cancer Prev Res (Phila); 2019 Dec; 12(12):831-836. PubMed ID: 31554630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.
    Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G;
    Fam Cancer; 2020 Oct; 19(4):337-346. PubMed ID: 32385704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australia.
    Tan YY; Spurdle AB; Obermair A
    J Pers Med; 2014 May; 4(2):218-44. PubMed ID: 25563224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and postassessment of nurse practitioners' knowledge of hereditary colorectal cancer.
    Edwards QT; Maradiegue A; Seibert D; Jasperson K
    J Am Acad Nurse Pract; 2011 Jul; 23(7):361-9. PubMed ID: 21696485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual health in cancer: the results of a survey exploring practices, attitudes, knowledge, communication, and professional interactions in oncology healthcare providers.
    Almont T; Farsi F; Krakowski I; El Osta R; Bondil P; Huyghe É
    Support Care Cancer; 2019 Mar; 27(3):887-894. PubMed ID: 30109489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet.
    Kaur R; McDonald C; Meiser B; Macrae F; Smith SK; Kang YJ; Caruana M; Mitchell G
    Adv Genet (Hoboken); 2022 Jun; 3(2):2100046. PubMed ID: 36618023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.